Stockreport

Athersys Announces Fast Track Designation From FDA for MultiStem® Program for Acute Respiratory Distress Syndrome

Athersys, Inc.  (ATHX) 
Last athersys, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: athersys.com/press-releases
PDF CLEVELAND, May 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its clinical program evaluating MultiStem® cell therapy for the treatmen [Read more]